Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-06-26
1999-12-14
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
574 21, 574 2, 530350, 530324, 530325, A61K 3810
Patent
active
060018062
ABSTRACT:
This invention relates to the use of the baculovirus glycoprotein, Interferon Stimulating Protein (ISP) (also known as gp67, gp64 EFP, or gp64), or the gene sequence encoding ISP, to stimulate production of interferon, such as for immunotherapy, anti-viral, anti-cancer, anti-bacterial, or anti-parasitic therapy. This invention also relates to novel mutant forms of ISP that show enhanced biological (i.e., anti-viral) activity, increased stability, higher yield or better solubility.
REFERENCES:
patent: 5750383 (1998-05-01), Blissard et al.
patent: 5770192 (1998-06-01), Cayley et al.
patent: 5846714 (1998-12-01), Haskill et al.
patent: 5871986 (1999-02-01), Boyce
Whitford, M. et al., J. Of Virology, 63(3):1393-1399 (Mar. 1989)
Genbank entry, Accession No. AAA72760.
Genbank entry, Accession No. AAA66758.
Bednarik Daniel P.
Gronowski Ann
Hilbert David M.
Murphy Marianne
Nardelli Bernadetta
Hoover Kenley K.
Humn Genome Sciences, Inc.
MacMillan Keith D.
Washington University
Wessendorf T. D.
LandOfFree
Interferon stimulating protein and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interferon stimulating protein and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interferon stimulating protein and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863456